ABSTRACT
After one year of absence, the 18th Annual Meeting of the Association for Cancer Immunotherapy (CIMT), Europe’s cancer immunotherapy meeting, took place virtually from 10 to 12 May 2021. Over 850 academic and clinical professionals from 30 countries met to discuss the recent advancements in cancer immunotherapy and the current progress in COVID19-related research. This meeting report summarizes the highlights of CIMT2021.
Acknowledgments
The authors would like to thank all the speakers of CIMT2021, whose lectures formed the basis of this report.
Disclosure statement
No potential conflict of interest was reported by the author(s).